26 this month. I’m going to call out paper #3 because I think it’s super important. 1) High buprenorphine-related mortality is persistent in Finland. Kriikku P, Häkkinen M, Ojanperä I. Forensic Sci Int. 2018 Aug 17;291:76-82. doi: 10.1016/j.forsciint.2018.08.010. [Epub ahead of print] Comments: This is an interesting topic. Finland seems to have a lot ofRead More
PubMed Update March-June 2018
Life is busy and so are all these writers – 109 papers. This is four months of article updates so a bit overwhelming. Sorry about that. I tried to help by creating some categories, but there are still 35 uncategorized. 26 naloxone papers: 1) Naloxone prescriptions from the emergency department: An initiative in evolution.Read More
PubMed Update September-October 2017
51 in two months, continuing to run solid. 1) Using Group Visits to Provide Overdose Education and Distribute Naloxone to High-Risk Primary Care Patients. Bair MJ. Pain Med. 2017 Nov 1. doi: 10.1093/pm/pnx279. [Epub ahead of print] No abstract available. Comment: Described in the title, this is a commentary on a quasi-experimental study in Veterans’ Administration clinics. Read More
PubMed Update February-May 2017
Sorry this took so long. This was partly due to my schedule and partly because we’ve been in a process of transitioning to PrescribeToPrevent. You can thank those unnamed persons who reached out to me asking when the next installment was coming for avoiding a much greater delay! 108 articles in four months. TheRead More
PubMed Update March 2016
23 this month. 1) Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. McDonald R, Strang J. Addiction. 2016 Mar 30. doi: 10.1111/add.13326. [Epub ahead of print] Review. Comments: Take-home naloxone meets all Bradford Hill criteria for causality in reducing opioid overdose mortality. Incidence of fatality among overdoses in the setting ofRead More